Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Single-Cell-State Culture of Human Pluripotent Stem Cells Increases Transfection Efficiency.

Nii T, Kohara H, Marumoto T, Sakuma T, Yamamoto T, Tani K.

Biores Open Access. 2016 May 1;5(1):127-36. doi: 10.1089/biores.2016.0009. eCollection 2016.

2.

Phase I clinical trial of a five-peptide cancer vaccine combined with cyclophosphamide in advanced solid tumors.

Murahashi M, Hijikata Y, Yamada K, Tanaka Y, Kishimoto J, Inoue H, Marumoto T, Takahashi A, Okazaki T, Takeda K, Hirakawa M, Fujii H, Okano S, Morita M, Baba E, Mizumoto K, Maehara Y, Tanaka M, Akashi K, Nakanishi Y, Yoshida K, Tsunoda T, Tamura K, Nakamura Y, Tani K.

Clin Immunol. 2016 May;166-167:48-58. doi: 10.1016/j.clim.2016.03.015. Epub 2016 Apr 9.

PMID:
27072896
3.

Stainless-Steel Ball-Milling Method for Hydro-/Deutero-genation using H2O/D2O as a Hydrogen/Deuterium Source.

Sawama Y, Kawajiri T, Niikawa M, Goto R, Yabe Y, Takahashi T, Marumoto T, Itoh M, Kimura Y, Monguchi Y, Kondo S, Sajiki H.

ChemSusChem. 2015 Nov;8(22):3773-6. doi: 10.1002/cssc.201501019. Epub 2015 Oct 23.

PMID:
26493945
4.

Improved hematopoietic differentiation of primate embryonic stem cells by inhibition of the PI3K-AKT pathway under defined conditions.

Nii T, Marumoto T, Kohara H, Yamaguchi S, Kawano H, Sasaki E, Kametani Y, Tani K.

Exp Hematol. 2015 Oct;43(10):901-911.e4. doi: 10.1016/j.exphem.2015.06.001. Epub 2015 Jun 12.

PMID:
26073521
5.

Analysis of essential pathways for self-renewal in common marmoset embryonic stem cells.

Nii T, Marumoto T, Kawano H, Yamaguchi S, Liao J, Okada M, Sasaki E, Miura Y, Tani K.

FEBS Open Bio. 2014 Feb 21;4:213-9. doi: 10.1016/j.fob.2014.02.007. eCollection 2014.

6.

Characterization of common marmoset dysgerminoma-like tumor induced by the lentiviral expression of reprogramming factors.

Yamaguchi S, Marumoto T, Nii T, Kawano H, Liao J, Nagai Y, Okada M, Takahashi A, Inoue H, Sasaki E, Fujii H, Okano S, Ebise H, Sato T, Suyama M, Okano H, Miura Y, Tani K.

Cancer Sci. 2014 Apr;105(4):402-8. doi: 10.1111/cas.12367. Epub 2014 Apr 5.

7.

Inhibition of PTEN tumor suppressor promotes the generation of induced pluripotent stem cells.

Liao J, Marumoto T, Yamaguchi S, Okano S, Takeda N, Sakamoto C, Kawano H, Nii T, Miyamato S, Nagai Y, Okada M, Inoue H, Kawahara K, Suzuki A, Miura Y, Tani K.

Mol Ther. 2013 Jun;21(6):1242-50. doi: 10.1038/mt.2013.60. Epub 2013 Apr 9.

8.

Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice.

Friedmann-Morvinski D, Bushong EA, Ke E, Soda Y, Marumoto T, Singer O, Ellisman MH, Verma IM.

Science. 2012 Nov 23;338(6110):1080-4. doi: 10.1126/science.1226929. Epub 2012 Oct 18.

9.

Roles of p53 in various biological aspects of hematopoietic stem cells.

Nii T, Marumoto T, Tani K.

J Biomed Biotechnol. 2012;2012:903435. doi: 10.1155/2012/903435. Epub 2012 Jun 20. Review.

10.

[Development of novel immune therapies for solid tumors: phase I clinical trials in a single institute].

Hijikata Y, Murahashi-Iga M, Okazaki T, Tanaka Y, Odaira K, Okano S, Hisano T, Takahashi A, Marumoto T, Inoue H, Tani K.

Rinsho Ketsueki. 2012 May;53(5):487-92. Review. Japanese. No abstract available.

PMID:
22728549
11.

Molecular biology of glioma.

Marumoto T, Saya H.

Adv Exp Med Biol. 2012;746:2-11. doi: 10.1007/978-1-4614-3146-6_1. Review.

PMID:
22639155
12.

Coxsackievirus B3 is an oncolytic virus with immunostimulatory properties that is active against lung adenocarcinoma.

Miyamoto S, Inoue H, Nakamura T, Yamada M, Sakamoto C, Urata Y, Okazaki T, Marumoto T, Takahashi A, Takayama K, Nakanishi Y, Shimizu H, Tani K.

Cancer Res. 2012 May 15;72(10):2609-21. doi: 10.1158/0008-5472.CAN-11-3185. Epub 2012 Mar 29.

13.

Transdifferentiation of glioblastoma cells into vascular endothelial cells.

Soda Y, Marumoto T, Friedmann-Morvinski D, Soda M, Liu F, Michiue H, Pastorino S, Yang M, Hoffman RM, Kesari S, Verma IM.

Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4274-80. doi: 10.1073/pnas.1016030108. Epub 2011 Jan 24.

14.

[New strategies in anti-tumor immunotherapy].

Iga-Murahashi M, Hijikata Y, Suehiro Y, Inoue H, Tanaka Y, Shimoda S, Marumoto T, Okazai T, Yoshida K, Tsunoda T, Tani K.

Rinsho Ketsueki. 2010 Nov;51(11):1654-60. Review. Japanese. No abstract available.

PMID:
21157128
15.
16.

APOA-1 is a novel marker of erythroid cell maturation from hematopoietic stem cells in mice and humans.

Inoue T, Sugiyama D, Kurita R, Oikawa T, Kulkeaw K, Kawano H, Miura Y, Okada M, Suehiro Y, Takahashi A, Marumoto T, Inoue H, Komatsu N, Tani K.

Stem Cell Rev. 2011 Mar;7(1):43-52. doi: 10.1007/s12015-010-9140-7.

PMID:
20376577
17.

Development of a novel mouse glioma model using lentiviral vectors.

Marumoto T, Tashiro A, Friedmann-Morvinski D, Scadeng M, Soda Y, Gage FH, Verma IM.

Nat Med. 2009 Jan;15(1):110-6. doi: 10.1038/nm.1863. Epub 2009 Jan 4.

18.

The tumor suppressor WARTS activates the Omi / HtrA2-dependent pathway of cell death.

Kuninaka S, Nomura M, Hirota T, Iida S, Hara T, Honda S, Kunitoku N, Sasayama T, Arima Y, Marumoto T, Koja K, Yonehara S, Saya H.

Oncogene. 2005 Aug 11;24(34):5287-98.

PMID:
16007220
19.

Over-expression of Aurora-A targets cytoplasmic polyadenylation element binding protein and promotes mRNA polyadenylation of Cdk1 and cyclin B1.

Sasayama T, Marumoto T, Kunitoku N, Zhang D, Tamaki N, Kohmura E, Saya H, Hirota T.

Genes Cells. 2005 Jul;10(7):627-38.

20.

RNA interference targeting aurora kinase a suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells.

Hata T, Furukawa T, Sunamura M, Egawa S, Motoi F, Ohmura N, Marumoto T, Saya H, Horii A.

Cancer Res. 2005 Apr 1;65(7):2899-905.

21.

Aurora-A - a guardian of poles.

Marumoto T, Zhang D, Saya H.

Nat Rev Cancer. 2005 Jan;5(1):42-50. Review.

PMID:
15630414
22.

Cre-loxP-controlled periodic Aurora-A overexpression induces mitotic abnormalities and hyperplasia in mammary glands of mouse models.

Zhang D, Hirota T, Marumoto T, Shimizu M, Kunitoku N, Sasayama T, Arima Y, Feng L, Suzuki M, Takeya M, Saya H.

Oncogene. 2004 Nov 18;23(54):8720-30.

PMID:
15480417
23.

Spindle checkpoint function is required for mitotic catastrophe induced by DNA-damaging agents.

Nitta M, Kobayashi O, Honda S, Hirota T, Kuninaka S, Marumoto T, Ushio Y, Saya H.

Oncogene. 2004 Aug 26;23(39):6548-58.

PMID:
15221012
24.

Tumor suppressor WARTS ensures genomic integrity by regulating both mitotic progression and G1 tetraploidy checkpoint function.

Iida S, Hirota T, Morisaki T, Marumoto T, Hara T, Kuninaka S, Honda S, Kosai K, Kawasuji M, Pallas DC, Saya H.

Oncogene. 2004 Jul 8;23(31):5266-74.

PMID:
15122335
25.

Activation of m-calpain is required for chromosome alignment on the metaphase plate during mitosis.

Honda S, Marumoto T, Hirota T, Nitta M, Arima Y, Ogawa M, Saya H.

J Biol Chem. 2004 Mar 12;279(11):10615-23. Epub 2003 Dec 19.

26.

CENP-A phosphorylation by Aurora-A in prophase is required for enrichment of Aurora-B at inner centromeres and for kinetochore function.

Kunitoku N, Sasayama T, Marumoto T, Zhang D, Honda S, Kobayashi O, Hatakeyama K, Ushio Y, Saya H, Hirota T.

Dev Cell. 2003 Dec;5(6):853-64.

27.

Aurora-A kinase maintains the fidelity of early and late mitotic events in HeLa cells.

Marumoto T, Honda S, Hara T, Nitta M, Hirota T, Kohmura E, Saya H.

J Biol Chem. 2003 Dec 19;278(51):51786-95. Epub 2003 Oct 1.

28.

Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells.

Hirota T, Kunitoku N, Sasayama T, Marumoto T, Zhang D, Nitta M, Hatakeyama K, Saya H.

Cell. 2003 Sep 5;114(5):585-98.

29.

Heterolytic cleavage of dihydrogen promoted by sulfido-bridged tungsten-ruthenium dinuclear complexes.

Ohki Y, Matsuura N, Marumoto T, Kawaguchi H, Tatsumi K.

J Am Chem Soc. 2003 Jul 2;125(26):7978-88.

PMID:
12823020
30.

Roles of aurora-A kinase in mitotic entry and G2 checkpoint in mammalian cells.

Marumoto T, Hirota T, Morisaki T, Kunitoku N, Zhang D, Ichikawa Y, Sasayama T, Kuninaka S, Mimori T, Tamaki N, Kimura M, Okano Y, Saya H.

Genes Cells. 2002 Nov;7(11):1173-82.

31.

WARTS tumor suppressor is phosphorylated by Cdc2/cyclin B at spindle poles during mitosis.

Morisaki T, Hirota T, Iida S, Marumoto T, Hara T, Nishiyama Y, Kawasuzi M, Hiraoka T, Mimori T, Araki N, Izawa I, Inagaki M, Saya H.

FEBS Lett. 2002 Oct 9;529(2-3):319-24.

32.

A molecular marker diagnostic of a specific isolate of an arbuscular mycorrhizal fungus, Gigaspora margarita.

Yokoyama K, Tateishi T, Marumoto T, Saito M.

FEMS Microbiol Lett. 2002 Jul 2;212(2):171-5.

33.

Zyxin, a regulator of actin filament assembly, targets the mitotic apparatus by interacting with h-warts/LATS1 tumor suppressor.

Hirota T, Morisaki T, Nishiyama Y, Marumoto T, Tada K, Hara T, Masuko N, Inagaki M, Hatakeyama K, Saya H.

J Cell Biol. 2000 May 29;149(5):1073-86.

34.

A human homolog of Drosophila warts tumor suppressor, h-warts, localized to mitotic apparatus and specifically phosphorylated during mitosis.

Nishiyama Y, Hirota T, Morisaki T, Hara T, Marumoto T, Iida S, Makino K, Yamamoto H, Hiraoka T, Kitamura N, Saya H.

FEBS Lett. 1999 Oct 8;459(2):159-65.

35.
36.

[Correlation analysis between visual acuity and sitting postural parameters of young students].

Marumoto T, Sotoyama M, Villanueva MB, Jonai H, Yamada H, Kanai A, Saito S.

Nippon Ganka Gakkai Zasshi. 1997 May;101(5):393-9. Japanese.

PMID:
9170844
37.

[Cytoprotective effect of trehalose in cryopreservation of isolated cardiac myocytes].

Marumoto T, Motomura N, Nakajima S, Takahashi A, Wada Y, Oka T.

Nihon Geka Gakkai Zasshi. 1997 Mar;98(3):403. Japanese. No abstract available.

PMID:
9173227
38.

Kinetic studies on androstenedione production in ovarian microsomes from immature rats.

Yamazaki T, Marumoto T, Kominami S, Ishimura K, Yamamoto A, Takemori S.

Biochim Biophys Acta. 1992 May 8;1125(3):335-40.

PMID:
1596523
39.

[The influence of aging and different type of targets on eye accommodation].

Marumoto T.

Nippon Ganka Gakkai Zasshi. 1990 Feb;94(2):197-202. Japanese.

PMID:
2368647
40.

[The relationship between the accommodative state and wave length of color light].

Marumoto T, Yaginuma Y, Nagai H, Yamada H, Katou K, Saitou S, Kaneda K.

Nippon Ganka Gakkai Zasshi. 1988 Jan;92(1):121-6. Japanese. No abstract available.

PMID:
3389253
41.

[Study on accommodation under changes in luminance of visual object].

Yaginuma Y, Marumoto T, Nagai H, Yamada H, Kato K, Saito S, Kaneda K.

Nippon Ganka Gakkai Zasshi. 1987 Dec;91(12):1180-5. Japanese. No abstract available.

PMID:
3448901
42.

[Etiology of malignant rheumatoid arthritis. (3-3) From the viewpoint of cellular immunity].

Suzuta T, Marumoto K, Marumoto T.

Ryumachi. 1977 Jan;17(1):110-3. Japanese. No abstract available.

PMID:
847536

Supplemental Content

Loading ...
Support Center